West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
245.86
+1.51 (0.62%)
Mar 6, 2026, 4:00 PM EST - Market closed
WST Employees
West Pharmaceutical Services had 10,800 employees as of December 31, 2025. The number of employees increased by 200 or 1.89% compared to the previous year.
Employees
10,800
Change (1Y)
200
Growth (1Y)
1.89%
Revenue / Employee
$284,639
Profits / Employee
$45,713
Market Cap
17.71B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10,800 | 200 | 1.89% |
| Dec 31, 2024 | 10,600 | 0 | - |
| Dec 31, 2023 | 10,600 | -100 | -0.93% |
| Dec 31, 2022 | 10,700 | 635 | 6.31% |
| Dec 31, 2021 | 10,065 | 865 | 9.40% |
| Dec 31, 2020 | 9,200 | 1,000 | 12.20% |
| Dec 31, 2019 | 8,200 | 500 | 6.49% |
| Dec 31, 2018 | 7,700 | 200 | 2.67% |
| Dec 31, 2017 | 7,500 | 200 | 2.74% |
| Dec 31, 2016 | 7,300 | 200 | 2.82% |
| Dec 31, 2015 | 7,100 | 100 | 1.43% |
| Dec 31, 2014 | 7,000 | 100 | 1.45% |
| Dec 31, 2013 | 6,900 | 200 | 2.99% |
| Dec 31, 2012 | 6,700 | 400 | 6.35% |
| Dec 31, 2011 | 6,300 | -300 | -4.55% |
| Dec 31, 2010 | 6,600 | 192 | 3.00% |
| Dec 31, 2009 | 6,408 | 108 | 1.71% |
| Dec 31, 2008 | 6,300 | -178 | -2.75% |
| Dec 31, 2007 | 6,478 | 155 | 2.45% |
| Dec 31, 2006 | 6,323 | 753 | 13.52% |
| Dec 31, 2005 | 5,570 | 1,220 | 28.05% |
| Dec 31, 2004 | 4,350 | -15 | -0.34% |
| Dec 31, 2003 | 4,365 | 225 | 5.43% |
| Dec 31, 2002 | 4,140 | 180 | 4.55% |
| Dec 31, 2001 | 3,960 | -740 | -15.74% |
| Dec 31, 2000 | 4,700 | -100 | -2.08% |
| Dec 31, 1999 | 4,800 | 0 | - |
| Dec 31, 1998 | 4,800 | 0 | - |
| Dec 31, 1997 | 4,800 | -240 | -4.76% |
| Dec 31, 1996 | 5,040 | -170 | -3.26% |
| Dec 31, 1995 | 5,210 | 1,530 | 41.58% |
| Dec 31, 1994 | 3,680 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Becton, Dickinson and Company | 72,000 |
| Baxter International | 37,500 |
| Alcon | 25,942 |
| Solventum | 22,000 |
| Align Technology | 20,290 |
| The Cooper Companies | 15,000 |
| AptarGroup | 14,000 |
| Bausch + Lomb | 13,000 |
WST News
- 8 days ago - Best Dividend Aristocrats For March 2026 - Seeking Alpha
- 8 days ago - West to Participate in Upcoming Investor Conferences - PRNewsWire
- 18 days ago - West Announces Quarterly Dividend and Share Repurchase Program - PRNewsWire
- 23 days ago - West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - West Pharma forecasts 2026 profit above estimates on strong demand for drug components - Reuters
- 23 days ago - West Reports Fourth-Quarter and Full-Year 2025 Results - PRNewsWire
- 4 weeks ago - West Pharmaceutical Services, Inc. (WST) Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity Transcript - Seeking Alpha
- 5 weeks ago - West to Host Fourth-Quarter and Full-Year 2025 Conference Call - PRNewsWire